Mangoceuticals partners with Lilly and Novo Nordisk for GLP-1 access programs; $99/month membership

MANGOCEUTICALS, INC.

Launches MangoRx Direct and PeachesRx Direct providing access to Zepbound (Eli Lilly) and Wegovy (Novo Nordisk) via telehealth.
Membership fee $99/month includes unlimited virtual visits, progress tracking, lifestyle coaching; GLP-1 meds from $499/month cash-pay.
No insurance required; prescriptions fulfilled via LillyDirect Self Pay, NovoCare Pharmacy, or local pharmacies.
Company highlights White House deal lowering government GLP-1 pricing to $245/month and $50 Medicare copays from mid-2026.
CEO Jacob Cohen states program targets 42% of U.S. adults with obesity, aiming to make treatment simple and sustainable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.